Silk Road Medical Inc (NASDAQ:SILK)’s traded shares stood at 3.0 million during the latest session, with the company’s beta value hitting 1.53. At the last check today, the stock’s price was $27.49, to imply an increase of 0.77% or $0.21 in intraday trading. The SILK share’s 52-week high remains $27.34, putting it 0.55% up since that peak but still an impressive 77.88% since price per share fell to its 52-week low of $6.08. The company has a valuation of $1.12B, with an average of 1.04 million shares in intraday trading volume over the past 10 days and average of 1.92 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Silk Road Medical Inc (SILK), translating to a mean rating of 3.33. Of 7 analyst(s) looking at the stock, 0 analyst(s) give SILK a Sell rating. 0 of those analysts rate the stock as Overweight while 3 advise Hold as 4 recommend it as a Buy.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Silk Road Medical Inc (NASDAQ:SILK) trade information
After registering a 0.77% upside in the latest session, Silk Road Medical Inc (SILK) has traded red over the past five days. The 5-day price performance for the stock is 1.74%, and 1.36% over 30 days. With these gigs, the year-to-date price performance is 124.04%. Short interest in Silk Road Medical Inc (NASDAQ:SILK) saw shorts transact 3.15 million shares and set a 2.48 days time to cover.
The extremes give us $20 and $46 for target low and target high price respectively. As such, SILK has been trading -67.33% off suggested target high and 27.25% from its likely low.
Silk Road Medical Inc (SILK) estimates and forecasts
Looking at statistics comparing Silk Road Medical Inc share performance against respective industry, we note that the company has underperformed competitors. Silk Road Medical Inc (SILK) shares are 75.10% up over the last 6 months, with its year-to-date growth rate lower than industry average at -0.69% against 12.60%.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -3.21% for the past 5-year period. While 2024 is set for a 1.30% return in earnings, projections for the next 5 years are at 1.60% annually.
SILK Dividends
Silk Road Medical Inc has its next earnings report out on 2024-Nov-06. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Silk Road Medical Inc (NASDAQ:SILK)’s Major holders
Silk Road Medical Inc insiders hold 4.15% of total outstanding shares, with institutional holders owning 97.26% of the shares at 101.47% float percentage. In total, 97.26% institutions holds shares in the company, led by BLACKROCK INC. As of 2024-06-30, the company held over 3.37 million shares (or 8.5777% of shares), all amounting to roughly $91.06 million.
The next major institution holding the largest number of shares is VANGUARD GROUP INC with 2.97 million shares, or about 7.565% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $80.31 million.
We also have Vanguard Total Stock Market Index Fund and Baron Discovery Fund as the top two Mutual Funds with the largest holdings of the Silk Road Medical Inc (SILK) shares. Going by data provided on Jun 30, 2024, Vanguard Total Stock Market Index Fund holds roughly 1.2 shares. This is just over 2.95% of the total shares, with a market valuation of $33.0 million. Data from the same date shows that the other fund manager holds a little less at 1.17, or 2.89% of the shares, all valued at about 32.26 million.
